Game-changing weekly semaglutide therapy launched at unprecedented affordability ‘SUNDAE’ aims to bring advanced GLP-1 treatment within reach of … Continue reading ₹220 per shot, a health revolution: Eris unlocks next-gen diabetes care for millions